(Q35558523)

8 August 2017

1 reference

title

Stem cell transplantation for multiple sclerosis: what is the evidence? (English)

1 reference

8 August 2017

Stem cell transplantation for multiple sclerosis: What is the evidence? (English)

1 reference

https://api.crossref.org/works/10.1016/S0268-960X(03)00022-5

20 March 2024

1 reference

1 reference

https://api.crossref.org/works/10.1016/S0268-960X(03)00022-5

20 March 2024

author

Vasilios K Kimiskidis

2

object named as

Vassilios K. Kimiskidis

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14556778

20 March 2024

author name string

Athanasios Fassas

1

1 reference

8 August 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14556778

20 March 2024

publication date

1 December 2003

1 reference

full work available at URL

8 August 2017

https://api.elsevier.com/content/article/PII:S0268960X03000225?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0268-960X(03)00022-5

https://api.elsevier.com/content/article/PII:S0268960X03000225?httpAccept=text/plain

20 March 2024

1 reference

https://api.crossref.org/works/10.1016/S0268-960X(03)00022-5

20 March 2024

1 reference

8 August 2017

volume

17

1 reference

8 August 2017

issue

4

1 reference

8 August 2017

page(s)

233-240

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900022-5

8 August 2017

1 reference

7 January 2021

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900022-5

1 reference

7 January 2021

Axonal pathology in multiple sclerosis: relationship to neurologic disability

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900022-5

7 January 2021

Axonal degeneration in the pathogenesis of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900022-5

7 January 2021

Monoclonal antibody treatment exposes three mechanisms underlying the clinical course of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900022-5

7 January 2021

What is new in the treatment of multiple sclerosis?

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900022-5

7 January 2021

Drug treatment of multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900022-5

7 January 2021

Differentiation of multiple sclerosis subtypes: implications for treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900022-5

7 January 2021

Final analysis of the European multicenter trial on IFNbeta-1b in secondary-progressive MS

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900022-5

7 January 2021

Randomized controlled trial of interferon- beta-1a in secondary progressive MS: Clinical results

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900022-5

7 January 2021

Therapeutic effect of mitoxantrone combined with methylprednisolone in multiple sclerosis: a randomised multicentre study of active disease using MRI and clinical criteria

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900022-5

7 January 2021

Immunotherapy of multiple sclerosis: the end of the beginning

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900022-5

7 January 2021

Therapeutic approaches in multiple sclerosis: lessons from failed and interrupted treatment trials

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900022-5

7 January 2021

Rationale for bone marrow transplantation in the treatment of autoimmune diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900022-5

7 January 2021

Immune ablation followed by allogeneic or autologous bone marrow transplantation: a new treatment for severe autoimmune diseases?

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900022-5

7 January 2021

Haemopoietic stem cell transplantation for autoimmune diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900022-5

7 January 2021

New opportunities for the treatment of severe autoimmune diseases: bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900022-5

7 January 2021

Bone marrow transplantation for autoimmune diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900022-5

7 January 2021

Autologous haematopoietic stem cell transplants for autoimmune disease--feasibility and transplant-related mortality. Autoimmune Disease and Lymphoma Working Parties of the European Group for Blood and Marrow Transplantation, the European [...]

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900022-5

7 January 2021

Chronic-relapsing experimental autoimmune encephalomyelitis (CR-EAE): treatment and induction of tolerance, with high dose cyclophosphamide followed by syngeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900022-5

7 January 2021

Prevention and reversal of adoptively transferred, chronic relapsing experimental autoimmune encephalomyelitis with a single high dose cytoreductive treatment followed by syngeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900022-5

7 January 2021

Syngeneic bone marrow transplantation eliminates V beta 8.2 T lymphocytes from the spinal cord of Lewis rats with experimental allergic encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900022-5

7 January 2021

Allogeneic bone marrow transplant for chronic myelogenous leukemia in a patient with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900022-5

7 January 2021

Bone marrow transplantation in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900022-5

7 January 2021

Peripheral blood stem cell transplantation in the treatment of progressive multiple sclerosis: first results of a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900022-5

7 January 2021

T cell-depleted autologous hematopoietic stem cell transplantation for multiple sclerosis: report on the first three patients

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900022-5

7 January 2021

Autologous stem cell transplantation in progressive multiple sclerosis--an interim analysis of efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900022-5

7 January 2021

High-dose immunosuppressive therapy with PBPC support in the treatment of poor risk multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900022-5

7 January 2021

Peripheral blood stem cell transplantation in multiple sclerosis with busulfan and cyclophosphamide conditioning: report of toxicity and immunological monitoring

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900022-5

7 January 2021

MRI and CSF oligoclonal bands after autologous hematopoietic stem cell transplantation in MS.

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900022-5

7 January 2021

Autologous hematopoietic stem cell transplantation suppresses Gd-enhanced MRI activity in MS.

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900022-5

7 January 2021

Conference synopsis: hematopoietic stem cell therapy in autoimmune diseases, October 2001

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900022-5

7 January 2021

Infusion of marrow and spleen cells in irradiated NZB-Bl mice: amelioration of autoimmune disease

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900022-5

7 January 2021

Organ-specific and systemic autoimmune diseases originate from defects in hematopoietic stem cells

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900022-5

7 January 2021

Treatment of autoimmune diseases by hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900022-5

7 January 2021

Immune ablation with stem-cell rescue: a possible cure for systemic lupus erythematosus?

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900022-5

7 January 2021

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900022-5

1 reference

7 January 2021

Lupus: tinkering with haematopoietic stem cells

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900022-5

7 January 2021

High-dose chemotherapy and autologous hematopoietic stem cell transplantation in patients with rheumatoid arthritis: results of an open study to assess feasibility, safety, and efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900022-5

7 January 2021

Turning blood into brain: cells bearing neuronal antigens generated in vivo from bone marrow

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900022-5

7 January 2021

Hematopoietic stem cell transplantation for multiple sclerosis. A retrospective multicenter study.

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900022-5

7 January 2021

Multiple sclerosis flares associated with recombinant granulocyte colony-stimulating factor

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900022-5

7 January 2021

Collection of hematopoietic stem cells from patients with autoimmune diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900022-5

7 January 2021

Meta-analysis of the placebo-treated groups in clinical trials of progressive MS

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900022-5

7 January 2021

Occurrence of thyroid autoimmunity in relapsing remitting multiple sclerosis patients undergoing interferon-beta treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900022-5

7 January 2021

Pulsed monoclonal antibody treatment and autoimmune thyroid disease in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900022-5

7 January 2021

Circulating IgG antibodies against factors IX and VIII in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900022-5

7 January 2021

Guidelines for autologous blood and marrow stem cell transplantation in multiple sclerosis: a consensus report written on behalf of the European Group for Blood and Marrow Transplantation and the European Charcot Foundation. BMT-MS Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900022-5

7 January 2021

Cardiac adverse effects associated with mitoxantrone (Novantrone) therapy in patients with MS.

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900022-5

7 January 2021

A study of therapy-related acute leukaemia after mitoxantrone therapy for multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0268-960X%2803%2900022-5

7 January 2021

Notes on the pathogenesis of multiple sclerosis

3

1 reference

https://api.crossref.org/works/10.1016/S0268-960X(03)00022-5

Treatment of experimental allergic encephalomyelitis in rats with total body irradiation and syngeneic BMT

20 March 2024

26

1 reference

https://api.crossref.org/works/10.1016/S0268-960X(03)00022-5

Treatment of relapsing experimental autoimmune encephalomyelitis in rats with allogeneic bone marrow transplantation from a resistant strain

20 March 2024

27

1 reference

https://api.crossref.org/works/10.1016/S0268-960X(03)00022-5

Effective treatment of relapsing experimental autoimmune encephalomyelitis with pseudoautologous bone marrow transplantation

20 March 2024

29

1 reference

https://api.crossref.org/works/10.1016/S0268-960X(03)00022-5

Bone marrow transplantation for multiple sclerosis

20 March 2024

31

1 reference

https://api.crossref.org/works/10.1016/S0268-960X(03)00022-5

Autologous peripheral blood stem cell transplantation in a patient with multiple sclerosis and concomitant Ph+ acute leukemia

20 March 2024

33

1 reference

https://api.crossref.org/works/10.1016/S0268-960X(03)00022-5

Autologous stem cell therapy for treatment of autoimmune diseases

20 March 2024

47

1 reference

https://api.crossref.org/works/10.1016/S0268-960X(03)00022-5

20 March 2024

Identifiers

1 reference

8 August 2017

1 reference